Skip to main content

Chlorpheniramine / dextromethorphan / phenylephrine Pregnancy and Breastfeeding Warnings

Brand names: Balamine DM, C-Phen DM, CP Dec DM, Cardec DM, Cardec DM Drops, Ceron-DM, Ceron-DM Drops, Corfen-DM, Dec-Chlorphen DM, Dec-Chlorphen DM Drops, Donatussin DM, Ed A-Hist DM, Gencontuss, HistadecDM, Nasohist-DM Pediatric, Neo DM Drops, NeoTuss Plus, NoHist DM, Norel CS, Reme Tussin DM, Robitussin Cough & Allergy, Rondec-DM, Rondex-DM, Rondex-DM Drops, Tussplex DM

Medically reviewed by Last updated on Aug 3, 2023.

Chlorpheniramine / dextromethorphan / phenylephrine Pregnancy Warnings

Chlorpheniramine/dextromethorphan/phenylephrine has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Chlorpheniramine/dextromethorphan/phenylephrine is only recommended for use during pregnancy when benefit outweighs risk.

See references

Chlorpheniramine / dextromethorphan / phenylephrine Breastfeeding Warnings

There are no data on the excretion of chlorpheniramine/dextromethorphan/phenylephrine into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. Product Information. Rondec-DM (chlorpheniramine/dextromethorp/phenylephrine). Alliant Pharmaceuticals Inc. 2022.

References for breastfeeding information

  1. Product Information. Rondec-DM (chlorpheniramine/dextromethorp/phenylephrine). Alliant Pharmaceuticals Inc. 2022.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.